|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2001-9-17
|
|
pubmed:abstractText |
Losartan, the first of the angiotensin II receptor blockers (ARBs) to be introduced, has been studied extensively in comparison with other classes of antihypertensive agents. Less research has been conducted on the efficacy and tolerability of losartan compared with that of other ARBs.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0149-2918
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1166-79
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11558856-Adult,
pubmed-meshheading:11558856-Antihypertensive Agents,
pubmed-meshheading:11558856-Double-Blind Method,
pubmed-meshheading:11558856-Female,
pubmed-meshheading:11558856-Humans,
pubmed-meshheading:11558856-Hypertension,
pubmed-meshheading:11558856-Losartan,
pubmed-meshheading:11558856-Male,
pubmed-meshheading:11558856-Middle Aged,
pubmed-meshheading:11558856-Tetrazoles,
pubmed-meshheading:11558856-Treatment Outcome,
pubmed-meshheading:11558856-Uric Acid,
pubmed-meshheading:11558856-Valine
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial.
|
|
pubmed:affiliation |
Rush-Presbyterian/St Luke's Medical Center, Chicago, Illinois, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
